Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Packer

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor controlR J Packer, J M Boyett, A J Janss, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiationP R Thomas, M Deutsch, J L Kepner, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor controlR J Packer, J M Boyett, A J Janss, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiationP R Thomas, M Deutsch, J L Kepner, et al.
Pageof 19